JPRN-jRCTs031210002RecruitingPhase 2
Phase II study of concurrent intensity modulated radiation therapy with docetaxel, cisplatin and 5-FU for advanced squamous cell carcinoma of cervical esophagus in Japan - ISLAND-J study
Watanabe Akinori0 sites43 target enrollmentStarted: April 1, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
- Enrollment
- 43
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 2
Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid CancerThyroid Gland Anaplastic CarcinomaNCT01236547National Cancer Institute (NCI)123
Recruiting
Phase 2
Phase II study of dynamic intensity modulated radiotherapy in patients with borderline resectable pancreatic cancerinvasive pancreatic ductal adenocarcinomainvasive pancreatic ductal adenocarcinoma, borderline resectable pancreatic cancerJPRN-jRCTs041220150Mizuno Shugo42
Active, not recruiting
Unknown
IMAT-NeuroblastomaSpecialty: Cancer, Primary sub-specialty: Children's Cancer and LeukaemiaUKCRC code/ Disease: Cancer/ Malignant neoplasms of ill-defined, secondary and unspecified sitesNeuroblastomaCancerISRCTN10746820niversity of Birmingham50
Not yet recruiting
Phase 2
Phase II/III Clinical Trial of Intensity Modulated Radiation Therapy with Concurrent Cisplatin for Stage I â?? IV A Cervical CarcinomaCTRI/2013/06/003774niversity of California San Diego425
Completed
Not Applicable
Phase II study of preoperative intensity modulated radiotherapy with gemcitabine and S-1 in patients with locally advanced pancreas cancerPancreas cancerJPRN-UMIN0000086143rd department of surgery Tokyo Medical University48